Bayer (0P6S) Gets a Hold from Kepler Capital
Kepler Capital analyst Christian Faitz maintained a Hold rating on Bayer (0P6S – Research Report) on January 21 and set a price target of ...
Vividion Therapeutics Announces Promotion of Jean Bemis to Chief Operating Officer
Vividion Therapeutics, Inc., a clinical-stage biopharmaceutical company utilizing novel discovery technologies to unlock high ...
Dhanuka Agritech acquires global rights for 2 fungicides from Bayer in ₹165 crore deal
Dhanuka Agritech acquires global rights for fungicides Iprovalicarb and Triadineol from Bayer AG, expanding international ...
devdiscourse2d
Dhanuka Agritech Expands Globally with Acquisition of Bayer AG's Fungicides
Dhanuka Agritech has acquired international rights for two fungicides from Bayer AG for Rs 165 crore. The acquisition includes rights to Bayer's Melody brand, its sub-brands for Iprovalicarb, and ...
J.P. Morgan Sticks to Their Hold Rating for Bayer (0P6S)
In a report released today, Richard Vosser from J.P. Morgan maintained a Hold rating on Bayer (0P6S – Research Report), with a price target of ...
Joplin Globe3d
Leaps by Bayer Announces One of the Largest Global Surveys of Society’s Attitudes Toward Breakthrough Technologies
As leaders gather for the World Economic Forum Annual Meeting 2025 in Davos, Leaps by Bayer, the impact investing arm of Bayer, and Boston Consulting Group (BCG) announced the launch of one of the ...
Business Wire6d
New U.S. Survey Conducted On Behalf Of One A Day® by Bayer Highlights Four in Five GenZ Women Feel Societal Pressures Impact Their New Year’s Resolutions
A new survey commissioned by One A Day®, the multivitamin and supplement brand by Bayer rooted in more than 80 years of nutritional science, suggests ...
Ted Danson Flustered After Discovering Vanessa Bayer Connection
Saturday Night Live alum Vanessa Bayer has shocked Ted Danson with a surprising admission. The Cheers actor hosted Bayer on the January 15 episode of his podcast, Where Everybody Knows Your Name. The ...
Multiple Sclerosis News Today6d
Bayer’s MRI contrast agent effective with 60% less gadolinium: Data
Gadoquatrane, a contrast agent Bayer is developing for use in MRI scans, like those done in MS, uses 60% less gadolinium and ...